Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

84 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Review of the allocation criteria for heart transplant in Spain in 2023. SEC-Heart Failure Association/ONT/SECCE consensus document.
González-Costello J, Pérez-Blanco A, Delgado-Jiménez J, González-Vílchez F, Mirabet S, Sandoval E, Cuenca-Castillo J, Camino M, Segovia-Cubero J, Sánchez-Salado JC, Pérez de la Sota E, Almenar-Bonet L, Farrero M, Zataraín E, García-Cosío MD, Garrido I, Barge-Caballero E, Gómez-Bueno M, de Juan Bagudá J, Manito-Lorite N, López-Granados A, García-Guereta L, Blasco-Peiró T, Sarralde-Aguayo JA, Sobrino-Márquez M, de la Fuente-Galán L, Crespo-Leiro MG, Coll E, Gran-Ipiña F, Díaz-Molina B, Doñate L, Arribas-Leal JM, Sánchez-Vicario F, Atienza F, Rábago Juan-Aracil G, García-Quintana A, Martínez-Alpuente I, Riesgo-Gil F, Hernández-Montfort J, Oliver-Juan E, Sánchez-Rivas J, Padilla-Martínez M, Pérez-Villares JM, Miñambres E, Domínguez-Gil B. González-Costello J, et al. Among authors: mirabet s. Rev Esp Cardiol (Engl Ed). 2024 Jan;77(1):69-78. doi: 10.1016/j.rec.2023.11.001. Epub 2023 Nov 4. Rev Esp Cardiol (Engl Ed). 2024. PMID: 37926340 English, Spanish.
The use of proliferation signal inhibitors in the prevention and treatment of allograft vasculopathy in heart transplantation.
Delgado JF, Manito N, Segovia J, Almenar L, Arizón JM, Campreciós M, Crespo-Leiro MG, Díaz B, González-Vílchez F, Mirabet S, Palomo J, Roig E, de la Torre JM. Delgado JF, et al. Among authors: mirabet s. Transplant Rev (Orlando). 2009 Apr;23(2):69-79. doi: 10.1016/j.trre.2009.01.002. Transplant Rev (Orlando). 2009. PMID: 19298938 Review.
Steroid use in heart transplant patients in Spain in the current era: a multicenter survey.
Crespo-Leiro M, Delgado J, Almenar L, Arizón JM, Blasco T, Brossa V, De la Fuente L, Díaz B, Fernández-Yañez J, Garrido IP, Gómez Bueno M, González Vílchez F, Lage E, López López L, Mirabet S, Pérez-Villa F, Pulpón LA, Roig E, Vázquez de Prada JA. Crespo-Leiro M, et al. Among authors: mirabet s. Transplant Proc. 2009 Jul-Aug;41(6):2244-6. doi: 10.1016/j.transproceed.2009.06.081. Transplant Proc. 2009. PMID: 19715887
Prevalence and severity of renal dysfunction among 1062 heart transplant patients according to criteria based on serum creatinine and estimated glomerular filtration rate: results from the CAPRI study.
Crespo-Leiro MG, Delgado JF, Paniagua MJ, Vázquez de Prada JA, Fernandez-Yañez J, Almenar L, Diaz-Molina B, Roig E, Arizón JM, Alonso-Pulpón L, Garrido IP, Sanz ML, de la Fuente L, Mirabet S, Manito N, Muñiz J. Crespo-Leiro MG, et al. Among authors: mirabet s. Clin Transplant. 2010 Jul-Aug;24(4):E88-93. doi: 10.1111/j.1399-0012.2009.01178.x. Clin Transplant. 2010. PMID: 20030676
Clinical recommendations for the use of everolimus in heart transplantation.
Manito N, Delgado JF, Crespo-Leiro MG, González-Vílchez F, Almenar L, Arizón JM, Díaz B, Fernández-Yáñez J, Mirabet S, Palomo J, Rodríguez Lambert JL, Roig E, Segovia J. Manito N, et al. Among authors: mirabet s. Transplant Rev (Orlando). 2010 Jul;24(3):129-42. doi: 10.1016/j.trre.2010.01.005. Transplant Rev (Orlando). 2010. PMID: 20619801 Review.
Withdrawal of proliferation signal inhibitors due to adverse events in the maintenance phase of heart transplantation.
Gonzalez-Vilchez F, Vazquez de Prada JA, Almenar L, Arizon Del Prado JM, Mirabet S, Diaz-Molina B, Delgado JF, Gomez-Bueno M, Paniagua MJ, Perez-Villa F, Roig E, Martínez-Dolz L, Brossa V, Lambert JL, Segovia J, Crespo-Leiro MG, Ruiz-Cano MJ. Gonzalez-Vilchez F, et al. Among authors: mirabet s. J Heart Lung Transplant. 2012 Mar;31(3):288-95. doi: 10.1016/j.healun.2011.10.011. Epub 2011 Dec 1. J Heart Lung Transplant. 2012. PMID: 22133787
Rejection after conversion to a proliferation signal inhibitor in chronic heart transplantation.
González-Vílchez F, Vázquez de Prada JA, Paniagua MJ, Almenar L, Mirabet S, Gómez-Bueno M, Díaz-Molina B, Arizón JM, Delgado J, Pérez-Villa F, Crespo-Leiro MG, Martínez-Dolz L, Roig E, Segovia J, Lambert JL, Lopez-Granados A, Escribano P, Farrero M. González-Vílchez F, et al. Among authors: mirabet s. Clin Transplant. 2013 Nov-Dec;27(6):E649-58. doi: 10.1111/ctr.12241. Epub 2013 Sep 12. Clin Transplant. 2013. PMID: 24025040
Primary graft failure after heart transplantation: characteristics in a contemporary cohort and performance of the RADIAL risk score.
Cosío Carmena MD, Gómez Bueno M, Almenar L, Delgado JF, Arizón JM, González Vilchez F, Crespo-Leiro MG, Mirabet S, Roig E, Pérez Villa F, Fernández-Yañez JF, Lambert JL, Manito N, Fuente L, Sanz Julve ML, Pascual D, Rábago G, Millán I, Alonso-Pulpón LA, Segovia J. Cosío Carmena MD, et al. Among authors: mirabet s. J Heart Lung Transplant. 2013 Dec;32(12):1187-95. doi: 10.1016/j.healun.2013.08.004. J Heart Lung Transplant. 2013. PMID: 24263021
Use of mTOR inhibitors in chronic heart transplant recipients with renal failure: calcineurin-inhibitors conversion or minimization?
Gonzalez-Vilchez F, Vazquez de Prada JA, Paniagua MJ, Gomez-Bueno M, Arizon JM, Almenar L, Roig E, Delgado J, Lambert JL, Perez-Villa F, Sanz-Julve ML, Crespo-Leiro M, Segovia J, Lopez-Granados A, Martinez-Dolz L, Mirabet S, Escribano P, Diaz-Molina B, Farrero M, Blasco T. Gonzalez-Vilchez F, et al. Among authors: mirabet s. Int J Cardiol. 2014 Jan 15;171(1):15-23. doi: 10.1016/j.ijcard.2013.11.036. Epub 2013 Nov 23. Int J Cardiol. 2014. PMID: 24309084
Chronic renal dysfunction in maintenance heart transplant patients: the ICEBERG study.
González-Vílchez F, Arizón JM, Segovia J, Almenar L, Crespo-Leiro MG, Palomo J, Delgado JF, Mirabet S, Rábago G, Pérez-Villa F, Díaz B, Sanz ML, Pascual D, de la Fuente L, Guinea G; ICEBERG Study Group. González-Vílchez F, et al. Among authors: mirabet s. Transplant Proc. 2014 Jan-Feb;46(1):14-20. doi: 10.1016/j.transproceed.2013.09.031. Transplant Proc. 2014. PMID: 24507019
84 results